Category

Cohort News

Universal DX Announces Strategic Collaboration with Quest Diagnostics to Bring Advanced Colorectal Cancer Screening Blood Test to Patients and Providers in the United States

//
Categories
CAMBRDIGE, Mass. and SECAUCUS, N.J., Nov. 20, 2023 /PRNewswire/ — Universal DX (“UDX”), a biotech company on a mission to transform cancer into a curable disease, today announced a strategic collaboration with Quest Diagnostics (“Quest”) (NYSE: DGX), the nation’s leading...
Read More →